Concepedia

Pharmacokinetic and pharmacodynamic profile of donepezil HCl following evening administration

Tiseo, Rogers, Friedhoff

British Journal of Clinical Pharmacology · 1998 · 100 citations · 10 references

DOIFull text

Open access

Abstract

The measured pharmacokinetic and pharmacodynamic parameters for both 5 and 10 mg day(-1) donepezil administered in the evening are in good agreement with previous results obtained with morning administration, indicating no time of dosing effect.

References

10

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease

Samantha Rogers, Martin R. Farlow, Rachelle S. Doody et al. · Neurology · 1998 · 1.6K citations

, , +20

Donepezil Improves Cognition and Global Function in Alzheimer Disease<subtitle>A 15-Week, Double-blind, Placebo-Controlled Study</subtitle>

Sharon L. Rogers · Archives of Internal Medicine · 1998 · 771 citations

The Efficacy and Safety of Donepezil in Patients with Alzheimer's Disease: Results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial

Sharon L. Rogers, Lawrence Friedhoff · Dementia and Geriatric Cognitive Disorders · 1996 · 738 citations

Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study

Samantha Rogers, Lawrence Friedhoff · European Neuropsychopharmacology · 1998 · 293 citations

, , +8

Pharmacokinetic and pharmacodynamic profile of donepezil HCl following multiple oral doses

Rogers, Cooper, Sukovaty et al. · British Journal of Clinical Pharmacology · 1998 · 168 citations · Full text